image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 36.89
-5.31 %
$ 2.16 B
Market Cap
-9.66
P/E
1. INTRINSIC VALUE

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets.[ Read More ]

The intrinsic value of one TWST stock under the base case scenario is HIDDEN Compared to the current market price of 36.9 USD, Twist Bioscience Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart TWST

image
FINANCIALS
245 M REVENUE
20.41%
-217 M OPERATING INCOME
12.79%
-205 M NET INCOME
6.08%
-142 M OPERATING CASH FLOW
-14.54%
50.6 M INVESTING CASH FLOW
121.73%
911 K FINANCING CASH FLOW
-99.66%
81.5 M REVENUE
8.18%
-88.9 M OPERATING INCOME
-81.89%
-85.6 M NET INCOME
-88.10%
-6.38 M OPERATING CASH FLOW
67.16%
-711 K INVESTING CASH FLOW
86.43%
2.91 M FINANCING CASH FLOW
59.08%
Balance Sheet Decomposition Twist Bioscience Corporation
image
Current Assets 424 M
Cash & Short-Term Investments 336 M
Receivables 44.1 M
Other Current Assets 43.8 M
Non-Current Assets 352 M
Long-Term Investments 0
PP&E 203 M
Other Non-Current Assets 149 M
Current Liabilities 73.3 M
Accounts Payable 14.1 M
Short-Term Debt 14.9 M
Other Current Liabilities 44.4 M
Non-Current Liabilities 79.6 M
Long-Term Debt 79.2 M
Other Non-Current Liabilities 475 K
EFFICIENCY
Earnings Waterfall Twist Bioscience Corporation
image
Revenue 245 M
Cost Of Revenue 155 M
Gross Profit 89.7 M
Operating Expenses 307 M
Operating Income -217 M
Other Expenses -12.5 M
Net Income -205 M
RATIOS
36.61% GROSS MARGIN
36.61%
-88.60% OPERATING MARGIN
-88.60%
-83.48% NET MARGIN
-83.48%
-32.82% ROE
-32.82%
-26.35% ROA
-26.35%
-35.03% ROIC
-35.03%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Twist Bioscience Corporation
image
Net Income -205 M
Depreciation & Amortization 29.3 M
Capital Expenditures -27.8 M
Stock-Based Compensation 30.3 M
Change in Working Capital -1.01 M
Others 2.56 M
Free Cash Flow -170 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Twist Bioscience Corporation
image
Wall Street analysts predict an average 1-year price target for TWST of $46 , with forecasts ranging from a low of $40 to a high of $53 .
TWST Lowest Price Target Wall Street Target
40 USD 8.43%
TWST Average Price Target Wall Street Target
46 USD 24.70%
TWST Highest Price Target Wall Street Target
53 USD 43.67%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Twist Bioscience Corporation
image
Sold
0-3 MONTHS
4.66 M USD 7
3-6 MONTHS
1.12 M USD 6
6-9 MONTHS
675 K USD 7
9-12 MONTHS
144 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
6 days ago
Nov 11, 2024
Sell 109 K USD
CHESS ROBERT
Director
- 2324
46.9894 USD
6 days ago
Nov 11, 2024
Sell 60.9 K USD
CHESS ROBERT
Director
- 1276
47.755 USD
6 days ago
Nov 11, 2024
Sell 72.3 K USD
Cho Dennis
See Remarks
- 1507
47.998 USD
6 days ago
Nov 11, 2024
Sell 496 K USD
Finn Patrick John
President and COO
- 10340
47.998 USD
6 days ago
Nov 11, 2024
Sell 64.7 K USD
Green Paula
SVP of Human Resources
- 1347
47.998 USD
6 days ago
Nov 11, 2024
Sell 382 K USD
Leproust Emily M.
Chief Executive Officer
- 7968
47.998 USD
1 week ago
Nov 06, 2024
Sell 639 K USD
Leproust Emily M.
Chief Executive Officer
- 14334
44.605 USD
1 week ago
Nov 06, 2024
Sell 246 K USD
Green Paula
SVP of Human Resources
- 5519
44.605 USD
1 week ago
Nov 06, 2024
Sell 64.6 K USD
WERNER ROBERT F.
Chief Accounting Officer
- 1448
44.605 USD
1 week ago
Nov 06, 2024
Sell 186 K USD
Laponis Adam
Chief Financial Officer
- 4160
44.605 USD
1 week ago
Nov 06, 2024
Sell 278 K USD
Finn Patrick John
President and COO
- 6239
44.605 USD
1 week ago
Nov 06, 2024
Sell 80.8 K USD
Cho Dennis
See Remarks
- 1811
44.605 USD
1 week ago
Nov 04, 2024
Sell 43.9 K USD
Green Paula
SVP of Human Resources
- 1057
41.564 USD
1 week ago
Nov 04, 2024
Sell 27.4 K USD
Cho Dennis
See Remarks
- 659
41.564 USD
1 week ago
Nov 04, 2024
Sell 201 K USD
Leproust Emily M.
Chief Executive Officer
- 4841
41.564 USD
1 week ago
Nov 04, 2024
Sell 111 K USD
Finn Patrick John
President and COO
- 2681
41.564 USD
1 week ago
Nov 04, 2024
Sell 6.48 K USD
WERNER ROBERT F.
Chief Accounting Officer
- 156
41.564 USD
3 weeks ago
Oct 23, 2024
Sell 97.4 K USD
Finn Patrick John
President and COO
- 2261
43.091 USD
1 month ago
Oct 09, 2024
Sell 35.8 K USD
Laponis Adam
Chief Financial Officer
- 856
41.812 USD
1 month ago
Oct 02, 2024
Sell 143 K USD
Green Paula
SVP of Human Resources
- 3310
43.211 USD
1 month ago
Oct 02, 2024
Sell 588 K USD
Leproust Emily M.
Chief Executive Officer
- 13605
43.211 USD
1 month ago
Oct 02, 2024
Sell 297 K USD
Finn Patrick John
President and COO
- 6865
43.211 USD
1 month ago
Oct 02, 2024
Sell 134 K USD
Cho Dennis
See Remarks
- 3104
43.211 USD
1 month ago
Sep 20, 2024
Sell 11 K USD
Cho Dennis
See Remarks
- 234
46.941 USD
1 month ago
Sep 20, 2024
Sell 13.9 K USD
Green Paula
SVP of Human Resources
- 297
46.941 USD
1 month ago
Sep 20, 2024
Sell 81.2 K USD
Leproust Emily M.
Chief Executive Officer
- 1730
46.941 USD
2 months ago
Sep 16, 2024
Sell 4.36 K USD
Cho Dennis
See Remarks
- 94
46.422 USD
2 months ago
Sep 06, 2024
Sell 10.8 K USD
Cho Dennis
See Remarks
- 275
39.161 USD
2 months ago
Sep 06, 2024
Sell 35.7 K USD
Green Paula
SVP of Human Resources
- 912
39.161 USD
2 months ago
Sep 06, 2024
Sell 9.4 K USD
WERNER ROBERT F.
Chief Accounting Officer
- 240
39.161 USD
2 months ago
Sep 06, 2024
Sell 91.6 K USD
Leproust Emily M.
Chief Executive Officer
- 2340
39.161 USD
2 months ago
Aug 23, 2024
Sell 35.1 K USD
WERNER ROBERT F.
Chief Accounting Officer
- 813
43.142 USD
3 months ago
Aug 05, 2024
Sell 28.3 K USD
Cho Dennis
See Remarks
- 709
39.926 USD
3 months ago
Aug 05, 2024
Sell 115 K USD
Finn Patrick John
President and COO
- 2885
39.926 USD
3 months ago
Aug 05, 2024
Sell 205 K USD
Leproust Emily M.
Chief Executive Officer
- 5139
39.926 USD
3 months ago
Aug 05, 2024
Sell 45.4 K USD
Green Paula
SVP of Human Resources
- 1137
39.926 USD
3 months ago
Aug 05, 2024
Sell 6.71 K USD
WERNER ROBERT F.
Chief Accounting Officer
- 168
39.926 USD
3 months ago
Jul 23, 2024
Sell 125 K USD
Finn Patrick John
President and COO
- 2207
56.625 USD
4 months ago
Jul 09, 2024
Sell 41.2 K USD
Laponis Adam
Chief Financial Officer
- 842
48.913 USD
4 months ago
Jul 02, 2024
Sell 6.05 K USD
Cho Dennis
See Remarks
- 126
48.002 USD
4 months ago
Jul 02, 2024
Sell 53.5 K USD
Leproust Emily M.
Chief Executive Officer
- 1114
48.002 USD
4 months ago
Jul 02, 2024
Sell 15.5 K USD
Green Paula
SVP of Human Resources
- 322
48.002 USD
4 months ago
Jul 02, 2024
Sell 22.8 K USD
Finn Patrick John
President and COO
- 476
48.002 USD
4 months ago
Jun 20, 2024
Sell 85.6 K USD
Leproust Emily M.
Chief Executive Officer
- 1732
49.41 USD
4 months ago
Jun 20, 2024
Sell 14.7 K USD
Green Paula
SVP of Human Resources
- 297
49.41 USD
4 months ago
Jun 20, 2024
Sell 11.6 K USD
Cho Dennis
See Remarks
- 234
49.41 USD
5 months ago
Jun 14, 2024
Sell 4.85 K USD
Cho Dennis
See Remarks
- 95
51.0359 USD
5 months ago
Jun 06, 2024
Sell 14.2 K USD
Cho Dennis
See Remarks
- 276
51.329 USD
5 months ago
Jun 06, 2024
Sell 47.1 K USD
Green Paula
SVP of Human Resources
- 918
51.329 USD
5 months ago
Jun 06, 2024
Sell 12.4 K USD
WERNER ROBERT F.
Chief Accounting Officer
- 242
51.329 USD
5 months ago
Jun 06, 2024
Sell 124 K USD
Leproust Emily M.
Chief Executive Officer
- 2408
51.329 USD
5 months ago
May 23, 2024
Sell 142 K USD
WERNER ROBERT F.
Chief Accounting Officer
- 3361
42.322 USD
6 months ago
May 03, 2024
Sell 29.6 K USD
Banyai William
See Remark
- 798
37.134 USD
6 months ago
May 03, 2024
Sell 21.1 K USD
Cho Dennis
See Remarks
- 568
37.134 USD
6 months ago
May 03, 2024
Sell 33.8 K USD
Green Paula
SVP of Human Resources
- 910
37.134 USD
6 months ago
May 03, 2024
Sell 155 K USD
Leproust Emily M.
Chief Executive Officer
- 4163
37.134 USD
6 months ago
May 03, 2024
Sell 4.9 K USD
WERNER ROBERT F.
Chief Accounting Officer
- 132
37.134 USD
6 months ago
May 03, 2024
Sell 85.8 K USD
Finn Patrick John
President and COO
- 2311
37.134 USD
6 months ago
Apr 23, 2024
Sell 65.5 K USD
Finn Patrick John
President and COO
- 2174
30.121 USD
7 months ago
Apr 09, 2024
Sell 18.4 K USD
Laponis Adam
Chief Financial Officer
- 556
33.155 USD
7 months ago
Apr 02, 2024
Sell 16.1 K USD
Finn Patrick John
President and COO
- 492
32.736 USD
7 months ago
Apr 02, 2024
Sell 10.7 K USD
Banyai William
See Remark
- 327
32.736 USD
7 months ago
Apr 02, 2024
Sell 37.1 K USD
Leproust Emily M.
Chief Executive Officer
- 1132
32.736 USD
7 months ago
Apr 02, 2024
Sell 4.22 K USD
Cho Dennis
See Remarks
- 129
32.736 USD
7 months ago
Apr 02, 2024
Sell 7.5 K USD
Green Paula
SVP of Human Resources
- 229
32.736 USD
7 months ago
Mar 20, 2024
Sell 7.71 K USD
Cho Dennis
See Remarks
- 230
33.516 USD
7 months ago
Mar 20, 2024
Sell 14.8 K USD
Banyai William
See Remark
- 442
33.516 USD
7 months ago
Mar 20, 2024
Sell 37.8 K USD
Leproust Emily M.
Chief Executive Officer
- 1128
33.516 USD
7 months ago
Mar 20, 2024
Sell 6.7 K USD
Green Paula
SVP of Human Resources
- 200
33.516 USD
8 months ago
Mar 14, 2024
Sell 3.22 K USD
Cho Dennis
See Remarks
- 93
34.6 USD
8 months ago
Mar 06, 2024
Sell 10.2 K USD
Cho Dennis
See Remarks
- 272
37.43 USD
8 months ago
Mar 06, 2024
Sell 6.77 K USD
WERNER ROBERT F.
Chief Accounting Officer
- 181
37.43 USD
8 months ago
Mar 06, 2024
Sell 55.7 K USD
Leproust Emily M.
Chief Executive Officer
- 1487
37.43 USD
8 months ago
Mar 06, 2024
Sell 22.5 K USD
Green Paula
SVP of Human Resources
- 600
37.43 USD
8 months ago
Mar 06, 2024
Sell 20.5 K USD
Banyai William
See Remark
- 549
37.43 USD
9 months ago
Feb 08, 2024
Sell 144 K USD
CHESS ROBERT
Director
- 4110
34.984 USD
1 year ago
May 10, 2023
Bought 132 K USD
Cho Dennis
See Remarks
+ 10000
13.2 USD
1 year ago
Feb 09, 2023
Sell 45.8 K USD
Starovasnik Melissa A.
- 1732
26.455 USD
1 year ago
Feb 09, 2023
Sell 45.8 K USD
JOHANNESSEN JAN
- 1732
26.455 USD
1 year ago
Jan 04, 2023
Sell 7.02 K USD
Banyai William
director: See Remarks
- 292
24.05 USD
1 year ago
Nov 21, 2022
Sell 31.7 K USD
Banyai William
director: See Remarks
- 1275
24.9 USD
2 years ago
Oct 25, 2022
Sell 11.2 K USD
Banyai William
director: See Remarks
- 379
29.55 USD
2 years ago
Oct 03, 2022
Sell 11.5 K USD
Banyai William
director: See Remarks
- 318
36.14 USD
2 years ago
Sep 16, 2022
Sell 319 K USD
Green Paula
SVP of Human Resources
- 8514
37.4302 USD
2 years ago
Aug 19, 2022
Sell 53.5 K USD
Banyai William
director: See Remarks
- 1275
41.94 USD
2 years ago
Aug 16, 2022
Sell 45 K USD
THORBURN JAMES M
Chief Financial Officer
- 900
49.9676 USD
2 years ago
Aug 17, 2022
Sell 294 K USD
THORBURN JAMES M
Chief Financial Officer
- 6093
48.3237 USD
2 years ago
Aug 16, 2022
Sell 124 K USD
THORBURN JAMES M
Chief Financial Officer
- 2418
51.2893 USD
2 years ago
Aug 16, 2022
Sell 142 K USD
THORBURN JAMES M
director: Chief Financial Officer
- 2907
48.9158 USD
2 years ago
Aug 16, 2022
Sell 82 K USD
THORBURN JAMES M
Chief Financial Officer
- 1582
51.8224 USD
2 years ago
Jul 22, 2022
Sell 16.3 K USD
Banyai William
director: See Remarks
- 378
43.19 USD
2 years ago
Jul 01, 2022
Sell 11.7 K USD
Banyai William
director: See Remarks
- 318
36.79 USD
2 years ago
Jun 15, 2022
Sell 307 K USD
Green Paula
director: SVP of Human Resources
- 10067
30.4682 USD
2 years ago
May 20, 2022
Sell 47.2 K USD
Banyai William
director: See Remarks
- 1275
37.04 USD
2 years ago
May 20, 2022
Sell 64.8 K USD
THORBURN JAMES M
Chief Financial Officer
- 1850
35.0422 USD
2 years ago
May 20, 2022
Sell 90.6 K USD
THORBURN JAMES M
Chief Financial Officer
- 2526
35.8778 USD
2 years ago
May 20, 2022
Sell 77.6 K USD
THORBURN JAMES M
Chief Financial Officer
- 2101
36.9246 USD
2 years ago
May 20, 2022
Sell 5.39 K USD
THORBURN JAMES M
Chief Financial Officer
- 143
37.7169 USD
2 years ago
May 23, 2022
Sell 14.8 K USD
THORBURN JAMES M
Chief Financial Officer
- 406
36.5521 USD
2 years ago
May 20, 2022
Sell 19.2 K USD
THORBURN JAMES M
director: Chief Financial Officer
- 517
37.1766 USD
2 years ago
May 11, 2022
Bought 250 K USD
BARTHELEMY NICOLAS
director:
+ 8550
29.251 USD
2 years ago
Apr 22, 2022
Sell 12.8 K USD
Banyai William
director: See Remarks
- 378
33.98 USD
2 years ago
Apr 14, 2022
Sell 235 K USD
THORBURN JAMES M
director: Chief Financial Officer
- 5493
42.7145 USD
2 years ago
Apr 14, 2022
Sell 49.1 K USD
THORBURN JAMES M
Chief Financial Officer
- 1127
43.5245 USD
2 years ago
Apr 01, 2022
Sell 17 K USD
Banyai William
director: See Remarks
- 318
53.61 USD
2 years ago
Mar 03, 2022
Sell 109 K USD
THORBURN JAMES M
director: Chief Financial Officer
- 2107
51.9646 USD
2 years ago
Mar 03, 2022
Sell 65 K USD
THORBURN JAMES M
Chief Financial Officer
- 1230
52.806 USD
2 years ago
Mar 03, 2022
Sell 9.66 K USD
THORBURN JAMES M
Chief Financial Officer
- 180
53.68 USD
2 years ago
Feb 22, 2022
Sell 67.4 K USD
Banyai William
- 1280
52.66 USD
2 years ago
Feb 22, 2022
Sell 128 K USD
THORBURN JAMES M
- 2461
52.0345 USD
2 years ago
Feb 22, 2022
Sell 70.9 K USD
THORBURN JAMES M
- 1341
52.8814 USD
2 years ago
Feb 22, 2022
Sell 34.3 K USD
THORBURN JAMES M
- 640
53.6641 USD
2 years ago
Feb 16, 2022
Sell 296 K USD
JOHANNESSEN JAN
- 5000
59.2 USD
2 years ago
Feb 04, 2022
Sell 14.9 K USD
CHESS ROBERT
- 253
58.879 USD
2 years ago
Feb 04, 2022
Sell 14.9 K USD
JOHANNESSEN JAN
- 253
58.879 USD
2 years ago
Feb 01, 2022
Sell 39.9 K USD
Finn Patrick John
- 659
60.52 USD
2 years ago
Jan 25, 2022
Sell 19 K USD
Banyai William
- 348
54.73 USD
2 years ago
Jan 21, 2022
Sell 13.1 K USD
Banyai William
- 245
53.36 USD
2 years ago
Jan 18, 2022
Sell 17.2 K USD
Leproust Emily M.
- 286
60.0318 USD
2 years ago
Jan 04, 2022
Sell 24.4 K USD
Banyai William
- 292
83.49 USD
2 years ago
Dec 29, 2021
Sell 453 K USD
Finn Patrick John
- 5994
75.62 USD
2 years ago
Dec 27, 2021
Sell 157 K USD
Leproust Emily M.
- 1962
80.1196 USD
2 years ago
Dec 27, 2021
Sell 157 K USD
Leproust Emily M.
- 1938
80.8594 USD
2 years ago
Dec 27, 2021
Sell 90 K USD
Leproust Emily M.
- 1100
81.8304 USD
2 years ago
Dec 27, 2021
Sell 16.5 K USD
Leproust Emily M.
- 200
82.43 USD
2 years ago
Dec 27, 2021
Sell 8.38 K USD
Leproust Emily M.
- 100
83.8 USD
2 years ago
Dec 22, 2021
Sell 510 K USD
Finn Patrick John
- 5994
85.09 USD
2 years ago
Dec 21, 2021
Sell 18.1 K USD
Finn Patrick John
- 219
82.85 USD
2 years ago
Dec 21, 2021
Sell 325 K USD
Weiss Patrick
- 3918
82.85 USD
2 years ago
Dec 15, 2021
Sell 309 K USD
Banyai William
- 3700
83.4972 USD
2 years ago
Dec 15, 2021
Sell 993 K USD
Banyai William
- 11769
84.3632 USD
2 years ago
Dec 15, 2021
Sell 373 K USD
Banyai William
- 4370
85.2897 USD
2 years ago
Dec 15, 2021
Sell 104 K USD
Banyai William
- 1206
86.303 USD
2 years ago
Dec 15, 2021
Sell 44.3 K USD
Banyai William
- 506
87.5685 USD
2 years ago
Dec 15, 2021
Sell 217 K USD
Banyai William
- 2439
88.8836 USD
2 years ago
Dec 15, 2021
Sell 90.4 K USD
Banyai William
- 1010
89.4976 USD
2 years ago
Dec 14, 2021
Sell 235 K USD
Weiss Patrick
- 2801
84 USD
2 years ago
Dec 08, 2021
Sell 250 K USD
Leproust Emily M.
- 3009
83.0329 USD
2 years ago
Dec 08, 2021
Sell 92.7 K USD
Leproust Emily M.
- 1100
84.3118 USD
2 years ago
Dec 08, 2021
Sell 253 K USD
Leproust Emily M.
- 2851
88.6204 USD
2 years ago
Dec 08, 2021
Sell 16.7 K USD
THORBURN JAMES M
- 200
83.34 USD
2 years ago
Dec 08, 2021
Sell 22.9 K USD
THORBURN JAMES M
- 267
85.7219 USD
2 years ago
Dec 08, 2021
Sell 52.2 K USD
THORBURN JAMES M
- 600
87.0783 USD
2 years ago
Dec 08, 2021
Sell 73.4 K USD
THORBURN JAMES M
- 831
88.3733 USD
2 years ago
Dec 08, 2021
Sell 215 K USD
THORBURN JAMES M
- 2399
89.7293 USD
2 years ago
Dec 08, 2021
Sell 200 K USD
THORBURN JAMES M
- 2212
90.5147 USD
2 years ago
Dec 08, 2021
Sell 44.9 K USD
THORBURN JAMES M
- 491
91.3493 USD
2 years ago
Dec 02, 2021
Sell 102 K USD
Finn Patrick John
- 1172
87.06 USD
2 years ago
Dec 02, 2021
Sell 52.7 K USD
Finn Patrick John
- 586
90 USD
2 years ago
Nov 24, 2021
Sell 267 K USD
Weiss Patrick
- 2801
95.29 USD
2 years ago
Nov 22, 2021
Sell 29.1 K USD
Banyai William
- 300
96.97 USD
2 years ago
Nov 22, 2021
Sell 158 K USD
Banyai William
- 1601
98.5507 USD
2 years ago
Nov 22, 2021
Sell 189 K USD
Banyai William
- 1892
99.7319 USD
2 years ago
Nov 22, 2021
Sell 399 K USD
Banyai William
- 3966
100.6648 USD
2 years ago
Nov 22, 2021
Sell 400 K USD
Banyai William
- 3926
101.8069 USD
2 years ago
Nov 22, 2021
Sell 401 K USD
Banyai William
- 3900
102.8552 USD
2 years ago
Nov 22, 2021
Sell 204 K USD
Banyai William
- 1967
103.7835 USD
2 years ago
Nov 22, 2021
Sell 255 K USD
Banyai William
- 2431
104.9227 USD
3 years ago
Nov 17, 2021
Sell 576 K USD
JOHANNESSEN JAN
- 5000
115.17 USD
3 years ago
Nov 15, 2021
Sell 432 K USD
Leproust Emily M.
- 3764
114.733 USD
3 years ago
Nov 15, 2021
Sell 772 K USD
Leproust Emily M.
- 6676
115.6844 USD
3 years ago
Nov 04, 2021
Sell 1.14 M USD
Leproust Emily M.
- 8208
138.7716 USD
3 years ago
Nov 05, 2021
Sell 209 K USD
Leproust Emily M.
- 1501
139.3856 USD
3 years ago
Nov 03, 2021
Sell 222 K USD
Leproust Emily M.
- 1718
129.2045 USD
3 years ago
Nov 03, 2021
Sell 542 K USD
Leproust Emily M.
- 4165
130.2373 USD
3 years ago
Nov 03, 2021
Sell 395 K USD
Leproust Emily M.
- 3007
131.3537 USD
3 years ago
Nov 02, 2021
Sell 1.11 M USD
Leproust Emily M.
- 8641
128.9987 USD
3 years ago
Nov 03, 2021
Sell 249 K USD
Leproust Emily M.
- 1884
132.2534 USD
3 years ago
Nov 02, 2021
Sell 68.2 K USD
Leproust Emily M.
- 525
129.9548 USD
3 years ago
Nov 03, 2021
Sell 120 K USD
Leproust Emily M.
- 900
133.3811 USD
3 years ago
Nov 03, 2021
Sell 206 K USD
Leproust Emily M.
- 1534
134.342 USD
3 years ago
Nov 02, 2021
Sell 224 K USD
Finn Patrick John
- 1758
127.23 USD
3 years ago
Nov 01, 2021
Sell 481 K USD
CHESS ROBERT
- 4000
120.1534 USD
3 years ago
Oct 25, 2021
Sell 155 K USD
Banyai William
See Remarks
- 1335
115.7896 USD
3 years ago
Oct 25, 2021
Sell 101 K USD
Banyai William
See Remarks
- 863
117.13 USD
3 years ago
Oct 25, 2021
Sell 899 K USD
Banyai William
See Remarks
- 7619
117.9605 USD
3 years ago
Oct 25, 2021
Sell 1.18 M USD
Banyai William
See Remarks
- 9974
118.6762 USD
3 years ago
Oct 21, 2021
Sell 164 K USD
Leproust Emily M.
- 1358
120.6199 USD
3 years ago
Oct 21, 2021
Sell 46.4 K USD
Leproust Emily M.
- 382
121.3634 USD
3 years ago
Oct 21, 2021
Sell 445 K USD
CHESS ROBERT
- 3700
120.146 USD
3 years ago
Oct 19, 2021
Sell 36 K USD
CHESS ROBERT
- 300
120 USD
3 years ago
Oct 13, 2021
Sell 510 K USD
Weiss Patrick
- 4906
104 USD
3 years ago
Oct 13, 2021
Sell 192 K USD
Leproust Emily M.
- 1740
110.1617 USD
3 years ago
Oct 12, 2021
Sell 814 K USD
THORBURN JAMES M
- 8000
101.76 USD
7. News
Twist Bioscience's Earnings Preview: Partnerships And Valuation Make It A 'Buy' Since I last covered it, Twist Bioscience has made significant strides. They have secured new partnerships, launched innovative products, and secured strategic financial agreements. TWST's valuation multiples now appear more reasonable, making it a compelling buy for new investors, with a long cash runway and potential self-sustainability by 2025-2026. The company has improved its gross margins and reduced EBIT margins, signaling rapid margin improvement and benefiting from economies of scale. seekingalpha.com - 1 week ago
Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of the FlexPrep™ Ultra-High Throughput Library Preparation Kit, designed with a proprietary Twist-developed enzyme to enable throughput at a low cost, and accelerate the adoption of NGS by microarray users in population and agricultural genomics (agrigenomics). businesswire.com - 2 weeks ago
Twist Bioscience to Present at Baird Global Healthcare Conference 2024 SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Baird Global Healthcare Conference 2024 in New York City on Tuesday, September 10 at 2:35 p.m. Eastern Time. The presentation will be webcast live and can be accessed by visiting the “I. businesswire.com - 2 months ago
3 Healthcare AI Stocks Positioned for Potential Breakthroughs Markets tanked on Monday because the Japanese central bank raised its interest rate to 0.25%. Interest rates were originally at a benchmark between 0 and 0.1, meaning a minor 15- to 25-basis-point increase had significant consequences for investors who were making margin calls with Yen. investorplace.com - 3 months ago
The 3 Best Med Tech Stocks to Buy Now According to the Advanced Medical Technology Association, med tech is defined as “companies that develop, manufacture, and distribute the technologies, devices, equipment, diagnostic tests, and health information systems.” The organization reports that these firms favorably change health care with “earlier disease detection, less-invasive procedures, and more effective treatments. investorplace.com - 3 months ago
Twist Bioscience: Lowered Biopharma Expectations Amid Financial Strain (Rating Downgrade) Twist Bioscience reported revenue of $81.5 million in Q2 (fiscal Q3), marking a 28% increase from Q2, 2023. Twist's biopharma segment underperformed, contributing to a significant impairment charge. The company's future relies on its synthetic biology segment, facing competition and uncertain prospects in a rapidly evolving market. seekingalpha.com - 3 months ago
Twist Bioscience Corporation (TWST) Q3 2024 Earnings Call Transcript Twist Bioscience Corporation (NASDAQ:TWST ) Q3 2024 Earnings Conference Call August 2, 2024 8:00 AM ET Company Participants Angela Bitting - Senior Vice President, Corporate Affairs Emily Leproust - Chief Executive Officer & Co-Founder Adam Laponis - Chief Financial Officer Patrick Finn - President and COO Conference Call Participants Steven Mah - Cowen Matt Larew - William Blair Luke Sergott - Barclays Vijay Kumar - Evercore ISI Sung-Ji Nam - Scotiabank Subbu Nambi - Guggenheim Securities Puneet Souda - Leerink Partners Tom Peterson - Baird Thomas DeBourcy - Nephron Research Operator Good day, and thank you for standing by. Welcome to Twist Bioscience Fiscal 2024 Third Quarter Financial Results Conference Call. seekingalpha.com - 3 months ago
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates Twist Bioscience (TWST) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to loss of $1.01 per share a year ago. zacks.com - 3 months ago
Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the third quarter of fiscal 2024 ended June 30, 2024. "We once again surpassed our revenue guidance, ending the quarter with $81.5 million in revenue, and exceeded our targets for both cash burn and gross margin," said Emily M. businesswire.com - 3 months ago
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP. zacks.com - 3 months ago
Twist Bioscience (TWST) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Twist Bioscience (TWST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 3 months ago
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates. zacks.com - 3 months ago
8. Profile Summary

Twist Bioscience Corporation TWST

image
COUNTRY US
INDUSTRY Medical - Diagnostics & Research
MARKET CAP $ 2.16 B
Dividend Yield 0.00%
Description Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
Contact 681 Gateway Boulevard, South San Francisco, CA, 94080 https://www.twistbioscience.com
IPO Date Oct. 31, 2018
Employees 919
Officers Dr. Michael Fero Ph.D. Chief Information Officer Dr. Emily Marine Leproust Ph.D. Co-Founder, Chairman & Chief Executive Officer Dr. Aaron K. Sato Ph.D. Chief Scientific Officer Mr. Adam Laponis Chief Financial Officer Dr. Patrick John Finn Ph.D. President & Chief Operating Officer Ms. Paula Green Senior Vice President of Human Resources Mr. Siyuan Chen Chief Technology Officer Ms. Angela Bitting Chief ESG Officer & Senior Vice President of Corporate Affairs Mr. Robert F. Werner Vice President & Chief Accounting Officer Dr. William Charles Banyai Ph.D. Senior Vice President of Advanced Development, GM of Data Storage & Director